Out of Control - Senior Programmer Analyst Meditech Employee Review

2.0
Jun 28, 2023
Recommend
CEO approval
Business Outlook

Pros

Great lower management, peers, and environment

Cons

I'd say we are going backwards, but that would be a good thing given the company's past. Upper management is clueless, right up to the CEO. For years since before covid, most were allowed to work from home full-time and in most cases productivity improved by doing so. Some buildings were sold during this time, and now that covid is over we are forced to come into the office once a week (a much longer commute for many that lived closer to the sold buildings). We are told it is to foster a "collaborative work environment", when it is most definitely to justify owning the remaining offices. Promoting from within has led to a team of unqualified people at the helm making bad decisions resulting in the need for layoffs. For 50 years we took pride in never having layoffs, until now. If we were going to go back on a promise, we should have stopped forcing people to drive multiple hours each way for little to no gain, and sold some more buildings instead of getting rid of people who were told we would never lay anyone off. Telling us our bonuses are being cut and laying people off while the CEO and executives get a 6-figure raise is probably not the way to go.

Explore other reviews about Meditech

5.0
Nov 23, 2025
Recommend
CEO approval
Business Outlook

Pros

Pretty good environment to work in

Cons

A lot of travel which is both good and bad

2.0
Jul 12, 2026
Recommend
CEO approval
Business Outlook

Pros

MEDITECH is surviving, which wasn't a certainty ten years ago. Considering the low starting salaries for greater Boston, the company tends to be less selective in who they hire compared to other employers. Even with the effect that AI is having on tech hiring.

Cons

The market was MEDITECH's to lose, and they lost it. Without HCA as a customer MEDITECH would be finished. Considerations for job applicants such as inclusiveness and work/life balance are largely irrelevant, as the company's long-term prospects for success are doubtful. MaaS subscriptions don't bring in enough money to make up for the business that was lost to market leader Epic Systems. I am a MEDITECH shareholder, so I see the financial reports. Although I'm pleased that dividends continue to be paid, they are draining the company of badly needed cash to fund a turnaround.

4
See reviews by: Helpful|Rating|Date|All